Immune markers are predictive of CMV infection in seropositive lung transplant recipients

被引：0
|
作者：
Gardiner, Bradley [1 ,2 ]
Lee, Sue [1 ]
Robertson, Allisa N. [1 ]
Snell, Gregory I. [2 ,3 ]
Westall, Glen P. [2 ,3 ]
Peleg, Anton Y. [1 ,2 ]
机构：
[1] Monash Univ, Sch Translat Med, Melbourne, Vic, Australia
[2] Alfred Hlth, Dept Resp Med, Lung Transplant Serv, Melbourne, Vic, Australia
[3] Alfred Hlth, Dept Infect Dis, Melbourne, Vic, Australia
来源：
TRANSPLANTATION | 2024年 / 108卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
222.6
引用
收藏
页码：40 / 40
页数：1
相关论文
共 50 条
  • [21] CMV infection in renal transplant recipients
    不详
    VOX SANGUINIS, 2005, 89 : 49 - 49
  • [22] Impact of recipient age on mortality among Cytomegalovirus (CMV)-seronegative lung transplant recipients with CMV-seropositive donors
    Belga, Sara
    Hussain, Sarah
    Avery, Robin K.
    Nauroz, Zeba
    Durand, Christine M.
    King, Elizabeth A.
    Massie, Allan
    Segev, Dorry L.
    Connor, Avonne E.
    Bush, Errol L.
    Levy, Robert D.
    Shah, Pali
    Werbel, William A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : 615 - 625
  • [23] CMV IMMUNOGLOBULINS IN LUNG TRANSPLANT RECIPIENTS
    Rossetti, Valeria
    Letizia, Corinna Morlacchi
    Musso, Valeria
    Renteria, Sara Uceda
    Lunghi, Giovanna
    Palleschi, Alessandro
    Tarsia, Paolo
    TRANSPLANT INTERNATIONAL, 2019, 32 : 167 - 168
  • [24] The effect of CMV-Immune globulin on outcomes in CMV-Mismatched lung transplant recipients
    Tavares de Melo, R. F.
    Lukose, T. S.
    Bae, S.
    Kubin, C. K.
    Lederer, D. J.
    Arcasoy, S. M.
    Wilt, J. S.
    Sonett, J. R.
    D'Ovidio, F.
    Kawut, S. M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (02): : S79 - S79
  • [25] CMV Infection and Lymphopenia: Warning Markers of Pneumocystis Pneumonia in Kidney Transplant Recipients
    Eberl, Isabelle
    Binquet, Christine
    Guilloteau, Adrien
    Legendre, Mathieu
    Dalle, Frederic
    Piroth, Lionel
    Tinel, Claire
    Blot, Mathieu
    TRANSPLANT INTERNATIONAL, 2024, 37
  • [26] Late Onset Cytomegalovirus (CMV) Infections in CMV-Seropositive Liver Transplant Recipients
    Kim, Jong Man
    Kim, Sung Joo
    Joh, Jae-Won
    Kwon, Choon Hyuck David
    Shin, Milljae
    Moon, Ju Ik
    Jung, Gum O.
    Choi, Gyu-Seong
    Hong, Seung Heui
    Lee, Suk-Koo
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 384 - 384
  • [27] Cost Effectiveness of Letermovir in Prevention of Clinically Significant CMV Infection in CMV Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (04) : 12 - 13
  • [28] A Multicenter Study of Valganciclovir Prophylaxis up to Day 120 in CMV-Seropositive Lung Transplant Recipients
    Monforte, V.
    Lopez, C.
    Santos, F.
    Zurbano, F.
    de la Torre, M.
    Sole, A.
    Gavalda, J.
    Ussetti, P.
    Lama, R.
    Cifrian, J.
    Borro, J. M.
    Pastor, A.
    Len, O.
    Bravo, C.
    Roman, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (05) : 1134 - 1141
  • [29] Safety and Effectiveness of Low-Dose Cytomegalovirus Valganciclovir Prophylaxis in CMV Seropositive Lung Transplant Recipients
    Lehikoinen, R. A.
    Syrjala, S.
    Heliovaara, E.
    Tikkanen, J.
    Lemstrom, K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S486 - S486
  • [30] Quantiferon-CMV Test, CMV-Specific ELISPOT and CMV-Dextramer Assays in Assessing the Risk of CMV Infection in Seropositive Kidney Transplant Recipients
    Lee, H.
    Park, K.
    Ryu, J.
    Yu, J.
    Chung, B.
    Yang, C.
    Oh, E. -J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 691 - 691
12345